Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer.

Jayasekera J, Schechter CB, Sparano JA, Jagsi R, White J, Chapman JW, Whelan T, Anderson SJ, Fyles AW, Sauerbrei W, Zellars RC, Li Y, Song J, Huang X, Julian TB, Luta G, Berry DA, Feuer EJ, Mandelblatt J; CISNET-BOLD Collaborative Group.

J Natl Cancer Inst. 2018 Sep 18. doi: 10.1093/jnci/djy128. [Epub ahead of print]

PMID:
30239794
2.

Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.

Jayasekera J, Li Y, Schechter CB, Jagsi R, Song J, White J, Luta G, Chapman JW, Feuer EJ, Zellars RC, Stout N, Julian TB, Whelan T, Huang X, Shelley Hwang E, Hopkins JO, Sparano JA, Anderson SJ, Fyles AW, Gray R, Sauerbrei W, Mandelblatt J, Berry DA; CISNET-BOLD Collaborative Group .

J Natl Cancer Inst. 2018 Apr 28. doi: 10.1093/jnci/djy059. [Epub ahead of print]

PMID:
29718314
3.

Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis.

Chesney TR, Yin JX, Rajaee N, Tricco AC, Fyles AW, Acuna SA, Scheer AS.

Radiother Oncol. 2017 Apr;123(1):1-9. doi: 10.1016/j.radonc.2017.02.019. Review.

PMID:
28391871
4.

TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer.

Valente SA, Tendulkar RD, Cherian S, O'Rourke C, Greif JM, Bailey L, Uhl V, Bethke KP, Donnelly ED, Rudolph R, Pederson A, Summer T, Lottich SC, Ross DL, Laronga C, Loftus L, Abbott AM, Kelemen P, Hermanto U, Friedman NB, Bedi GC, Joh JE, Thompson WA 3rd, Hoefer RA, Wilson JP, Kang SK, Rosen B, Ruffer J, Bravo L, Police A, Escallon JM, Fyles AW, McCready DR, Graves GM, Rohatgi N, Eaker JA, Graves J, Willey SC, Tousimis EA, Collins BT, Shaw CM, Riley L, Deb N, Kelly T, Andolino DL, Boisvert ME, Lyons J, Small W Jr, Grobmyer SR.

Ann Surg Oncol. 2016 Sep;23(9):2809-15. doi: 10.1245/s10434-016-5240-1. Epub 2016 May 9.

PMID:
27160524
5.

Omission of Breast Radiotherapy in Low-risk Luminal A Breast Cancer: Impact on Health Care Costs.

Han K, Yap ML, Yong JH, Mittmann N, Hoch JS, Fyles AW, Warde P, Gutierrez E, Lymberiou T, Foxcroft S, Liu FF.

Clin Oncol (R Coll Radiol). 2016 Sep;28(9):587-93. doi: 10.1016/j.clon.2016.04.003. Epub 2016 Apr 29.

PMID:
27139262
6.

Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes.

Han K, Pintilie M, Lipscombe LL, Lega IC, Milosevic MF, Fyles AW.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):507-12. doi: 10.1158/1055-9965.EPI-15-1008. Epub 2015 Dec 31.

7.

Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy.

Liu FF, Shi W, Done SJ, Miller N, Pintilie M, Voduc D, Nielsen TO, Nofech-Mozes S, Chang MC, Whelan TJ, Weir LM, Olivotto IA, McCready DR, Fyles AW.

J Clin Oncol. 2015 Jun 20;33(18):2035-40. doi: 10.1200/JCO.2014.57.7999. Epub 2015 May 11.

PMID:
25964246
8.

Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy.

Bane AL, Whelan TJ, Pond GR, Parpia S, Gohla G, Fyles AW, Pignol JP, Pritchard KI, Chambers S, Levine MN.

Ann Oncol. 2014 May;25(5):992-8. doi: 10.1093/annonc/mdu090. Epub 2014 Feb 20.

PMID:
24562444
9.

High tumor interstitial fluid pressure identifies cervical cancer patients with improved survival from radiotherapy plus cisplatin versus radiotherapy alone.

Milosevic MF, Pintilie M, Hedley DW, Bristow RG, Wouters BG, Oza AM, Laframboise S, Hill RP, Fyles AW.

Int J Cancer. 2014 Oct 1;135(7):1692-9. doi: 10.1002/ijc.28403. Epub 2014 Apr 25.

10.

The significance of tumoral ERCC1 status in patients with locally advanced cervical cancer treated with chemoradiation therapy: a multicenter clinicopathologic analysis.

Doll CM, Aquino-Parsons C, Pintilie M, Klimowicz AC, Petrillo SK, Milosevic M, Craighead PS, Clarke B, Lees-Miller SP, Fyles AW, Magliocco AM.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):721-7. doi: 10.1016/j.ijrobp.2012.06.021. Epub 2012 Jul 24.

PMID:
22836058
11.

Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation.

Chaudary N, Pintilie M, Hedley D, Fyles AW, Milosevic M, Clarke B, Hill RP, Mackay H.

Cancer. 2012 Jun 15;118(12):3105-15. doi: 10.1002/cncr.26635. Epub 2011 Oct 25.

12.

Follow-up for women after treatment for cervical cancer.

Elit L, Fyles AW, Oliver TK, Devries-Aboud MC, Fung-Kee-Fung M; members of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care.

Curr Oncol. 2010 Jun;17(3):65-9.

13.

Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ.

Williamson D, Dinniwell R, Fung S, Pintilie M, Done SJ, Fyles AW.

Radiother Oncol. 2010 Jun;95(3):317-20. doi: 10.1016/j.radonc.2010.03.021. Epub 2010 Apr 17.

PMID:
20400190
14.

Follow-up for women after treatment for cervical cancer: a systematic review.

Elit L, Fyles AW, Devries MC, Oliver TK, Fung-Kee-Fung M; Gynecology Cancer Disease Site Group.

Gynecol Oncol. 2009 Sep;114(3):528-35. doi: 10.1016/j.ygyno.2009.06.001. Epub 2009 Jun 26. Review.

PMID:
19560188
15.

Effect of distributional heterogeneity on the analysis of tumor hypoxia based on carbonic anhydrase IX.

Iakovlev VV, Pintilie M, Morrison A, Fyles AW, Hill RP, Hedley DW.

Lab Invest. 2007 Dec;87(12):1206-17. Epub 2007 Oct 1.

16.

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, Mason RP, Melillo G, Padhani AR, Powis G, Rajendran JG, Reba R, Robinson SP, Semenza GL, Swartz HM, Vaupel P, Yang D, Croft B, Hoffman J, Liu G, Stone H, Sullivan D.

Int J Radiat Biol. 2006 Oct;82(10):699-757. Review.

PMID:
17118889
17.

Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer.

Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M, Weir LM, Olivotto IA.

N Engl J Med. 2004 Sep 2;351(10):963-70.

18.

Estimating hypoxic status in human tumors: a simulation using Eppendorf oxygen probe data in cervical cancer patients.

Doll CM, Milosevic M, Pintilie M, Hill RP, Fyles AW.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1239-46.

PMID:
12654433
19.

Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy.

Rayan G, Dawson LA, Bezjak A, Lau A, Fyles AW, Yi QL, Merante P, Vallis KA.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):154-61.

PMID:
12504048
20.

Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation.

Haugland HK, Vukovic V, Pintilie M, Fyles AW, Milosevic M, Hill RP, Hedley DW.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):854-61.

PMID:
12095550
21.

Anemia, hypoxia and transfusion in patients with cervix cancer: a review.

Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP.

Radiother Oncol. 2000 Oct;57(1):13-9. Review.

PMID:
11033184
22.

Proliferation parameters in epidermoid carcinomas of the anal canal.

Wong CS, Tsang RW, Cummings BJ, Fyles AW, Couture J, Brierley JD, Pintilie M.

Radiother Oncol. 2000 Sep;56(3):349-53.

PMID:
10974385
23.

Interrelationship of proliferation and hypoxia in carcinoma of the cervix.

Tsang RW, Fyles AW, Milosevic M, Syed A, Pintilie M, Levin W, Manchul LA.

Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):95-9.

PMID:
10656379
24.

Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.

Tsang RW, Wong CS, Fyles AW, Levin W, Manchul LA, Milosevic M, Chapman W, Li YQ, Pintilie M.

Radiother Oncol. 1999 Jan;50(1):93-101.

PMID:
10225562
25.

Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.

Tsang RW, Fyles AW, Li Y, Rajaraman MM, Chapman W, Pintilie M, Wong CS.

Radiother Oncol. 1999 Jan;50(1):85-92.

PMID:
10225561
26.

The relationship between elevated interstitial fluid pressure and blood flow in tumors: a bioengineering analysis.

Milosevic MF, Fyles AW, Hill RP.

Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):1111-23.

PMID:
10192363
27.

Cervix cancer oxygenation measured following external radiation therapy.

Fyles AW, Milosevic M, Pintilie M, Hill RP.

Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):751-3.

PMID:
9845090
28.

Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis.

De Jaeger K, Merlo FM, Kavanagh MC, Fyles AW, Hedley D, Hill RP.

Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):717-21.

PMID:
9845083
29.

Oxygenation predicts radiation response and survival in patients with cervix cancer.

Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, Chapman W, Levin W, Manchul L, Keane TJ, Hill RP.

Radiother Oncol. 1998 Aug;48(2):149-56. Erratum in: Radiother Oncol 1999 Mar;50(3):371.

PMID:
9783886
30.

Interstitial fluid pressure in cervical carcinoma: within tumor heterogeneity, and relation to oxygen tension.

Milosevic MF, Fyles AW, Wong R, Pintilie M, Kavanagh MC, Levin W, Manchul LA, Keane TJ, Hill RP.

Cancer. 1998 Jun 15;82(12):2418-26.

PMID:
9635535
31.

Effect of filgrastim (G-CSF) during chemotherapy and abdomino-pelvic radiation therapy in patients with ovarian carcinoma.

Fyles AW, Manchul L, Levin W, Robertson JM, Sturgeon J, Tsuji D.

Int J Radiat Oncol Biol Phys. 1998 Jul 1;41(4):843-7.

PMID:
9652847
32.

A randomized study of two doses of abdominopelvic radiation therapy for patients with optimally debulked Stage I, II, and III ovarian cancer.

Fyles AW, Thomas GM, Pintilie M, Ackerman I, Levin W.

Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):543-9.

PMID:
9635700
33.

Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix.

Rakovitch E, Fyles AW, Pintilie M, Leung PM.

Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):979-87.

PMID:
9276362
34.

Laparoscopic ovarian transposition.

Covens AL, van der Putten HW, Fyles AW, Leung PM, O'Brien PF, Murphy KJ, DePetrillo AD.

Eur J Gynaecol Oncol. 1996;17(3):177-82.

PMID:
8780914
35.

Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.

Tsang RW, Fyles AW, Kirkbride P, Levin W, Manchul LA, Milosevic MF, Rawlings GA, Banerjee D, Pintilie M, Wilson GD.

Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1319-29.

PMID:
7635771
36.

Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis.

Fyles AW, Pintilie M, Kirkbride P, Levin W, Manchul LA, Rawlings GA.

Radiother Oncol. 1995 May;35(2):107-17.

PMID:
7569018
37.

Phylloides tumor of the breast: a report of 14 cases.

Hopkins ML, McGowan TS, Rawlings G, Liu FF, Fyles AW, Yeoh JL, Manchul L, Levin W.

J Surg Oncol. 1994 Jun;56(2):108-12.

PMID:
8007675
38.

Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: a 15-year review.

Carey MS, Dembo AJ, Simm JE, Fyles AW, Treger T, Bush RS.

Int J Gynecol Cancer. 1993 Jan;3(1):24-35.

PMID:
11578319
39.

Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment.

Manchul LA, Simm J, Levin W, Fyles AW, Dembo AJ, Pringle JF, Rawlings GA, Sturgeon JF, Thomas GM.

Int J Radiat Oncol Biol Phys. 1992;22(5):867-74.

PMID:
1555978
40.

Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma.

Fyles AW, Dembo AJ, Bush RS, Levin W, Manchul LA, Pringle JF, Rawlings GA, Sturgeon JF, Thomas GM, Simm J.

Int J Radiat Oncol Biol Phys. 1992;22(5):847-51.

PMID:
1555975
41.

Outcome of patients with unfavorable optimally cytoreduced ovarian cancer treated with chemotherapy and whole abdominal radiation.

Ledermann JA, Dembo AJ, Sturgeon JF, Fine S, Bush RS, Fyles AW, Pringle JF, Rawlings GA, Thomas GM, Simm J.

Gynecol Oncol. 1991 Apr;41(1):30-5.

PMID:
2026356

Supplemental Content

Loading ...
Support Center